![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 10, 2015 10:37:30 AM
Investigation for Investors in shares of Celladon Corp (NASDAQ:CLDN) over Acquisition announced
The takeover of Celladon is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:CLDN shares concerning whether the takeover of Celladon Corp. is unfair to NASDAQ:CLDN stockholders.
Investors who purchased shares of Celladon Corp (NASDAQ:CLDN) and currently hold any of those NASDAQ:CLDN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain officers and directors of Celladon Corp breached their fiduciary duties owed to NASDAQ:CLDN investors in connection with the proposed acquisition.
On November 18, 2015 Celladon Corp (NASDAQ:CLDN) and Eiger BioPharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that they have entered into a merger agreement under which the stockholders of Eiger would become the majority owners of Celladon, and the operations of Celladon and Eiger would be combined.
Recent EIGRQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 12:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 10:06:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 09:00:57 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM